Physician profile
Rafi Raza
NPI 1891785507
$10,112.81
in general payments reported to CMS, 2019-2025
7 companies · $28.42 in 2025
The $28.42 reported for 2025 was less than what a typical Neuroradiology provider received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,664 · 2020: $4,200 · 2022: $41.10 · 2024: $179 · 2025: $28.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $9,625.00 | 2019-2020 | |
| Medtronic USA, INC. | $239.47 | 2019 | |
| Baxter Healthcare | $130.80 | 2024 | Tisseel |
| Corcept Therapeutics | $48.02 | 2024 | Korlym |
| Bracco Diagnostics INC. | $28.42 | 2025 | |
| Cook Medical LLC | $23.32 | 2022 | |
| Lantheus Medical Imaging, INC. | $17.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafi Raza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.